These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 25794641)

  • 1. Expression/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells.
    Singh S; Kumar PU; Thakur S; Kiran S; Sen B; Sharma S; Rao VV; Poongothai AR; Ramakrishna G
    Tumour Biol; 2015 Aug; 36(8):6159-71. PubMed ID: 25794641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential sirtuin expression patterns in amyotrophic lateral sclerosis (ALS) postmortem tissue: neuroprotective or neurotoxic properties of sirtuins in ALS?
    Körner S; Böselt S; Thau N; Rath KJ; Dengler R; Petri S
    Neurodegener Dis; 2013; 11(3):141-52. PubMed ID: 22796962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of sirtuin 1 and 2 is associated with poor prognosis in non-small cell lung cancer patients.
    Grbesa I; Pajares MJ; Martínez-Terroba E; Agorreta J; Mikecin AM; Larráyoz M; Idoate MA; Gall-Troselj K; Pio R; Montuenga LM
    PLoS One; 2015; 10(4):e0124670. PubMed ID: 25915617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirtuin inhibitors, EX527 and AGK2, suppress cell migration by inhibiting HSF1 protein stability.
    Kim HW; Kim SA; Ahn SG
    Oncol Rep; 2016 Jan; 35(1):235-42. PubMed ID: 26530275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth.
    Ma L; Maruwge W; Strambi A; D'Arcy P; Pellegrini P; Kis L; de Milito A; Lain S; Brodin B
    Cell Death Dis; 2014 Oct; 5(10):e1483. PubMed ID: 25341037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High glucose-induced oxidative stress represses sirtuin deacetylase expression and increases histone acetylation leading to neural tube defects.
    Yu J; Wu Y; Yang P
    J Neurochem; 2016 May; 137(3):371-83. PubMed ID: 26896748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing sirtuin expression in endometrial carcinoma and non-neoplastic endometrium.
    Bartosch C; Monteiro-Reis S; Almeida-Rios D; Vieira R; Castro A; Moutinho M; Rodrigues M; Graça I; Lopes JM; Jerónimo C
    Oncotarget; 2016 Jan; 7(2):1144-54. PubMed ID: 26701732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol Induced Premature Senescence Is Associated with DNA Damage Mediated SIRT1 and SIRT2 Down-Regulation.
    Kilic Eren M; Kilincli A; Eren Ö
    PLoS One; 2015; 10(4):e0124837. PubMed ID: 25924011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression patterns of Sirtuin family members (SIRT1 TO SIRT7): Insights into pathogenesis and prognostic of Myelodysplastic neoplasm.
    Goes JVC; Viana MA; Sampaio LR; Cavalcante CBA; Melo MML; de Oliveira RTG; Borges DP; Gonçalves PG; Pinheiro RF; Ribeiro-Junior HL
    Gene; 2024 Jul; 915():148428. PubMed ID: 38575099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered levels of sirtuin genes (SIRT1, SIRT2, SIRT3 and SIRT6) and their target genes in adipose tissue from individual with obesity.
    Martínez-Jiménez V; Cortez-Espinosa N; Rodríguez-Varela E; Vega-Cárdenas M; Briones-Espinoza M; Ruíz-Rodríguez VM; López-López N; Briseño-Medina A; Turiján-Espinoza E; Portales-Pérez DP
    Diabetes Metab Syndr; 2019; 13(1):582-589. PubMed ID: 30641770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking sirtuin 1 and 2 inhibits renal interstitial fibroblast activation and attenuates renal interstitial fibrosis in obstructive nephropathy.
    Ponnusamy M; Zhou X; Yan Y; Tang J; Tolbert E; Zhao TC; Gong R; Zhuang S
    J Pharmacol Exp Ther; 2014 Aug; 350(2):243-56. PubMed ID: 24833701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a potent small molecule SIRT1/2 inhibitor with anticancer effects.
    Choi G; Lee J; Ji JY; Woo J; Kang NS; Cho SY; Kim HR; Ha JD; Han SY
    Int J Oncol; 2013 Oct; 43(4):1205-11. PubMed ID: 23900402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced gene expression of sirtuins and active AMPK levels in children and adolescents with obesity and insulin resistance.
    Arab Sadeghabadi Z; Nourbakhsh M; Pasalar P; Emamgholipour S; Golestani A; Larijani B; Razzaghy-Azar M
    Obes Res Clin Pract; 2018; 12(2):167-173. PubMed ID: 29150224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.
    Lara E; Mai A; Calvanese V; Altucci L; Lopez-Nieva P; Martinez-Chantar ML; Varela-Rey M; Rotili D; Nebbioso A; Ropero S; Montoya G; Oyarzabal J; Velasco S; Serrano M; Witt M; Villar-Garea A; Imhof A; Mato JM; Esteller M; Fraga MF
    Oncogene; 2009 Feb; 28(6):781-91. PubMed ID: 19060927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, in-vitro evaluation and molecular docking studies of novel indole derivatives as inhibitors of SIRT1 and SIRT2.
    Manjula R; Gokhale N; Unni S; Deshmukh P; Reddyrajula R; Srinivas Bharath MM; Dalimba U; Padmanabhan B
    Bioorg Chem; 2019 Nov; 92():103281. PubMed ID: 31561106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3.
    Disch JS; Evindar G; Chiu CH; Blum CA; Dai H; Jin L; Schuman E; Lind KE; Belyanskaya SL; Deng J; Coppo F; Aquilani L; Graybill TL; Cuozzo JW; Lavu S; Mao C; Vlasuk GP; Perni RB
    J Med Chem; 2013 May; 56(9):3666-79. PubMed ID: 23570514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2.
    Peck B; Chen CY; Ho KK; Di Fruscia P; Myatt SS; Coombes RC; Fuchter MJ; Hsiao CD; Lam EW
    Mol Cancer Ther; 2010 Apr; 9(4):844-55. PubMed ID: 20371709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-specific deregulation of selected HDACs characterizes ALS progression in mouse models: pharmacological characterization of SIRT1 and SIRT2 pathways.
    Valle C; Salvatori I; Gerbino V; Rossi S; Palamiuc L; René F; Carrì MT
    Cell Death Dis; 2014 Jun; 5(6):e1296. PubMed ID: 24946089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of NAD dependent de-acetylases SIRT1 and SIRT2 in B-Cell Chronic Lymphocytic Leukemia (CLL).
    Bhalla S; Gordon LI
    Cancer Biol Ther; 2016; 17(3):300-9. PubMed ID: 26794150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of SIRT1 inhibits proliferation and promotes apoptosis of paclitaxel-resistant human cervical cancer cells.
    Xia X; Zhou X
    Cell Mol Biol (Noisy-le-grand); 2018 May; 64(6):36-41. PubMed ID: 29808798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.